Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study
- PMID: 24183792
- DOI: 10.1016/j.ymgme.2013.10.011
Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study
Abstract
This article presents a new Dutch multicenter study ("PKU-COBESO") into cognitive and behavioral sequelae of early and continuously treated Phenylketonuria (PKU) patients. Part of the study sample will consist of young adult PKU patients who have participated in a large neuropsychological study approximately 10 years ago, when they were 7-to-15-year-olds (Huijbregts et al., 2002 [1]). Their neurocognitive development will be mapped in association with their earlier and continued metabolic history, taking into account possible changes in, for instance, medication. A second part of the sample will consist of PKU patients between the ages of 7 and approximately 40 years (i.e., born in or after 1974, when neonatal screening was introduced in The Netherlands), who have not participated in the earlier neuropsychological study. Again, their cognitive functioning will be related to their metabolic history. With respect to aspects of cognition, there will be an emphasis on executive functioning. The concept of executive functioning will however be extended with further emphasis on the impact of cognitive deficits on the daily lives of PKU patients, aspects of social cognition, social functioning, and behavior/mental health (i.e., COgnition, BEhavior, SOcial functioning: COBESO). In addition to a description of the PKU-COBESO study, some preliminary results with respect to mental health and social functioning will be presented in this article. Thirty adult PKU patients (mean age 27.8, SD 6.4) and 23 PKU patients under the age of 18 years (mean age 11.0, SD 3.3) were compared to 14 (mean age 26.9 years, SD 5.9) and 7 matched controls (mean age 10.5, SD 2.6) respectively, with respect to their scores on the Adult Self-Report or Child Behavior Checklist (measuring mental health problems) and the Social Skills Checklist or Social Skills Rating System (measuring social skills). Whereas there were very few significant group differences (except for mental health problems in the internalizing spectrum for adult PKU patients), possibly due to the small control groups, several significant associations between mental health problems and Phe levels were observed for the PKU patients. Childhood Phe levels and internalizing problems for adult PKU patients were related; concurrent Phe was associated with both internalizing and externalizing behavioral problems for those under the age of 18. These preliminary results underline the importance of early dietary adherence.
Keywords: ANT; ASR; Adult Self-Report; Amsterdam Neuropsychological Tasks; CBCL; Child Behavior Checklist; Childhood phenylalanine; LNAA; Mental health; PAH; PKU; PKU-COBESO; Phe; Phenylketonuria; Phenylketonuria cognition, behavior, social functioning study; SSC; SSRS; Social Skills Checklist; Social Skills Rating System; Social functioning; Tyr; large neutral amino acids; phenylalanine; phenylalanine hydroxylase; tyrosine.
© 2013.
Similar articles
-
Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study.J Inherit Metab Dis. 2016 May;39(3):355-362. doi: 10.1007/s10545-016-9918-0. Epub 2016 Feb 25. J Inherit Metab Dis. 2016. PMID: 26914933 Free PMC article.
-
Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.Neuropsychology. 2017 May;31(4):437-447. doi: 10.1037/neu0000358. Epub 2017 Mar 20. Neuropsychology. 2017. PMID: 28318283
-
Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study.Behav Genet. 2017 Sep;47(5):486-497. doi: 10.1007/s10519-017-9863-1. Epub 2017 Aug 3. Behav Genet. 2017. PMID: 28776207 Free PMC article.
-
Executive functioning in context: Relevance for treatment and monitoring of phenylketonuria.Mol Genet Metab. 2013;110 Suppl:S25-30. doi: 10.1016/j.ymgme.2013.10.001. Epub 2013 Oct 10. Mol Genet Metab. 2013. PMID: 24206933 Review.
-
The role of intelligence in phenylketonuria: a review of research and management.Mol Genet Metab. 2010;99 Suppl 1:S18-21. doi: 10.1016/j.ymgme.2009.10.015. Mol Genet Metab. 2010. PMID: 20123465 Review.
Cited by
-
Impact of Phenylketonuria on the Serum Metabolome and Plasma Lipidome: A Study in Early-Treated Patients.Metabolites. 2024 Aug 30;14(9):479. doi: 10.3390/metabo14090479. Metabolites. 2024. PMID: 39330486 Free PMC article.
-
Effects of LC-PUFA Supplementation in Patients with Phenylketonuria: A Systematic Review of Controlled Trials.Nutrients. 2019 Jul 6;11(7):1537. doi: 10.3390/nu11071537. Nutrients. 2019. PMID: 31284588 Free PMC article.
-
Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.Mol Genet Metab. 2018 Jan;123(1):6-20. doi: 10.1016/j.ymgme.2017.10.009. Epub 2017 Oct 19. Mol Genet Metab. 2018. PMID: 29331172 Free PMC article.
-
Initial results from the PHEFREE longitudinal natural history study: Cross-sectional observations in a cohort of individuals with phenylalanine hydroxylase (PAH) deficiency.Mol Genet Metab. 2024 Sep-Oct;143(1-2):108541. doi: 10.1016/j.ymgme.2024.108541. Epub 2024 Jul 22. Mol Genet Metab. 2024. PMID: 39059270 Free PMC article.
-
cAMP/PKA-CREB-BDNF signaling pathway in hippocampus of rats subjected to chemically-induced phenylketonuria.Metab Brain Dis. 2022 Feb;37(2):545-557. doi: 10.1007/s11011-021-00865-7. Epub 2021 Nov 20. Metab Brain Dis. 2022. PMID: 34800207
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical